MASS · XBRL financial data

908 Devices financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (MASS's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	42,206	46,852	50,229	59,631	56,197
Cost of revenue	18,973	20,829	24,907	29,775	27,774
Gross profit	23,233	26,023	25,322	29,856	28,423
Research and development	13,067	17,526	21,904	25,495	15,575
Selling, general and administrative	32,235	43,879	46,176	53,636	38,528
Total operating expenses	45,302	61,405	68,080	106,574	67,844
Operating income (loss)	(22,069)	(35,382)	(42,758)	(76,718)	(39,421)
Interest expense	486	129	201	—	—
Other income (expense)	386	(83)	(131)	(264)	(346)
Income tax expense (benefit)	—	0	(211)	(282)	(66)
Net income (loss)	(22,169)	(33,563)	(36,399)	(72,206)	19,489
Earnings per share, basic USD per share	(0.79)	(1.07)	(1.13)	(2.12)	0.54
Earnings per share, diluted USD per share	(0.79)	(1.07)	(1.13)	(2.12)	0.54
Weighted average shares, basic thousands of shares	27,958	31,493	32,239	34,076	35,899
Weighted average shares, diluted thousands of shares	27,958	31,493	32,239	34,076	35,899

Fiscal years (MASS's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	224,073	188,422	121,041	44,032	70,517
Marketable securities	—	0	24,641	25,568	42,453
Accounts receivable	16,375	10,033	8,989	12,627	11,327
Inventory	7,918	12,513	14,938	16,173	12,990
Prepaid and other current assets	4,527	4,658	4,181	4,655	7,272
Total current assets	252,893	215,626	173,790	103,055	144,559
Property and equipment, net	1,603	3,083	3,342	3,421	4,232
Right-of-use asset	5,182	3,956	6,233	6,910	4,397
Goodwill	—	10,050	10,367	0	0
Total assets	260,906	242,587	202,981	159,476	190,071
Accounts payable	1,371	1,397	1,191	2,063	1,586
Accrued liabilities	6,961	8,847	8,713	9,096	6,838
Total current liabilities	14,836	19,226	22,549	25,149	34,064
Long-term debt	15,000	15,000	—	—	—
Lease liability, non-current	4,508	3,040	3,929	4,742	3,947
Total liabilities	46,302	51,988	37,490	44,884	46,372
Accumulated deficit	(100,637)	(134,200)	(170,599)	(242,805)	(223,316)
Total stockholders' equity	214,604	190,599	165,491	114,592	143,699
Total liabilities and equity	260,906	242,587	202,981	159,476	190,071
Common shares outstanding (cover page) thousands of shares	31,234	32,047	32,910	35,330	37,380

Fiscal years (MASS's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(22,169)	(33,563)	(36,399)	(72,206)	19,489
Stock-based compensation	2,504	7,207	9,787	11,763	9,845
Depreciation and amortization	925	1,614	2,384	4,682	4,465
Net cash from operating activities	(29,082)	(20,930)	(25,059)	(30,247)	(23,688)
Purchases of property and equipment	737	2,045	2,045	602	955
Net cash from investing activities	(737)	(15,807)	(26,400)	(46,321)	50,747
Net cash from financing activities	94,725	1,179	(15,935)	(376)	(697)
Net change in cash	64,906	(35,540)	(67,381)	(77,009)	26,389

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
908 Devices	63,019	16,074	3,171*	41.3M	—	Q2 FY26 10-QJun 30, 2026
Quanterix	44,169	32,906	(5,119)*	47.3M	18.3 quarters	Q2 FY26 10-QJun 30, 2026
Frequency Electronics	61,407	23,451	2,622	11.3M	—	Q1 FY27 10-QJul 31, 2026
Quantum-Si	23,653	344	(18,444)*	not reported	6.1 quarters	Q2 FY26 10-QJun 30, 2026
Seer	26,075	3,102	(9,571)*	55.4M	16.0 quarters	Q2 FY26 10-QJun 30, 2026
Alamar Biosciences	132,969	29,427	(11,322)*	69.4M	22.1 quarters	Q2 FY26 10-QJun 30, 2026
Mesa Laboratories	30,695	60,138	14,736	5.6M	—	Q1 FY27 10-QJun 30, 2026
Rapid Micro Biosystems	14,687	8,054	(12,702)*	not reported	1.6 quarters	Q2 FY26 10-QJun 30, 2026
Pacific Biosciences of California	61,003	39,007	(35,583)*	310.8M	6.7 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.